Listed by the USPTO as YU, MISOOK
Tech Center 1600 • Art Units: 1600 1641 1642
This examiner grants 39% of resolved cases
YU, MISOOK examines in Tech Center 1600, Art Unit 1600. The profile includes 237 resolved cases and shows a 39.2% allowance rate. Interviews are associated with an 18.0% lift in allowance outcomes. The median days to allowance are 4540, making prosecution timing a central planning issue.
The listed company is Cytotheryx Inc., and the listed firm is BOZICEVIC, FIELD & FRANCIS LLP. The allowance result supports careful claim construction, evidence development, and amendment planning. The interview measure provides a reason to consider examiner engagement, but the extended median timing means that applicants should address procedural options and business deadlines early.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18362410 | IMMUNOMODULATORY PROTEINS AND RELATED METHODS | Non-Final OA | Flagship Pioneering Innovations VII, LLC |
| 18274152 | Genetically Modified Hepatocyte Populations | Non-Final OA | Cytotheryx, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy39.2% of resolved applications examined by Misook Yu were allowed (237 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +18.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Misook Yu took 4,540 days on average from filing to allowance.
Misook Yu examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
